Climb Bio (CLYM) Stock: Buy, Sell, or Hold?
$10.36
-0.51 (-4.69%)
âŧ
5d:
+0.68%
30d:
-5.04%
90d:
-40.6%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (37%)
Quality Score
31/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$9.65 â $11.15
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-10.4x
Next 12M consensus est.
Wall Street Target
$28.40
+174.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$8.49 / $12.44
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: CLYM is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When CLYM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CLYM is currently trading at $10.36, which is considered slightly high relative to its 30-day fair value range of $9.65 to $11.15.
Technical Outlook: Technically, CLYM is in a downtrend. Immediate support is located at $8.48, while resistance sits at $12.44. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: CLYM scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $28.40 (+174.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CLYM is in a downtrend. Immediate support is located at $8.48, while resistance sits at $12.44. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: CLYM scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $28.40 (+174.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$9.65 -
$11.15
Company Quality Score
31/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
36.8%
Trading Range & Key Levels
30-Day Trading Range
$9.65 -
$11.15
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$8.49
Resistance Level
$12.44
Current Trend
Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.7%)
- BULLISH: Trading 174.1% below Wall St target ($28.40)
- WARNING: Composite score 31/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-10.42
Wall Street Target
$28.40
(+174.1%)
Share CLYM Analysis
Share this live CLYM analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CLYM)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 27, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits shows a bullish sentiment towards $CLYM, with one user reporting a profitable gain of 7.5% in a short period. No recent news articles were found.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:28 PM ET
Data refreshes hourly during market hours. Next update: 6:28 PM
Data refreshes hourly during market hours. Next update: 6:28 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLYM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 52 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 43 HOLD |
|
ABVX
Abivax SA American DeposâĻ |
STRONG BUY
12 analysts |
$164 | 56 HOLD |
|
TSHA
Taysha Gene Therapies Inc |
STRONG BUY
13 analysts |
$13 | 50 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CLYM Research Pages
